S. Herschorn
AuthID: R-00F-A15
1
TÃTULO: Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo Full Text
AUTORES: Chapple, CR; Cruz, F ; Cardozo, L; Staskin, D; Herschorn, S; Choudhury, N; Stoelzel, M; Heesakkers, J; Siddiqui, E;
PUBLICAÇÃO: 2020, FONTE: EUROPEAN UROLOGY, VOLUME: 77, NÚMERO: 1
AUTORES: Chapple, CR; Cruz, F ; Cardozo, L; Staskin, D; Herschorn, S; Choudhury, N; Stoelzel, M; Heesakkers, J; Siddiqui, E;
PUBLICAÇÃO: 2020, FONTE: EUROPEAN UROLOGY, VOLUME: 77, NÚMERO: 1
2
TÃTULO: The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction Full Text
AUTORES: Carlos D'Ancona; Bernard Haylen; Matthias Oelke; Luis Abranches Monteiro; Edwin Arnold; Howard Goldman; Rizwan Humid; Yukio Homma; Tom Marcelissen; Kevin Rademakers; Alexis Schizas; Ajay Singla; Irela Soto; Vincent Tse; Stefan de Wachter; Sender Herschorn;
PUBLICAÇÃO: 2019, FONTE: NEUROUROLOGY AND URODYNAMICS, VOLUME: 38, NÚMERO: 2
AUTORES: Carlos D'Ancona; Bernard Haylen; Matthias Oelke; Luis Abranches Monteiro; Edwin Arnold; Howard Goldman; Rizwan Humid; Yukio Homma; Tom Marcelissen; Kevin Rademakers; Alexis Schizas; Ajay Singla; Irela Soto; Vincent Tse; Stefan de Wachter; Sender Herschorn;
PUBLICAÇÃO: 2019, FONTE: NEUROUROLOGY AND URODYNAMICS, VOLUME: 38, NÚMERO: 2
INDEXADO EM: 
Scopus 
WOS
Scopus WOS3
TÃTULO: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology (vol 30, pg 819, 2013) Full Text
AUTORES: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2014, FONTE: ADVANCES IN THERAPY, VOLUME: 31, NÚMERO: 2
AUTORES: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2014, FONTE: ADVANCES IN THERAPY, VOLUME: 31, NÚMERO: 2
4
TÃTULO: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Activity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology Full Text
AUTORES: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2013, FONTE: ADVANCES IN THERAPY, VOLUME: 30, NÚMERO: 9
AUTORES: Ginsberg, D; Cruz, F ; Herschorn, S; Gousse, A; Keppenne, V; Aliotta, P; Sievert, KD; Brin, MF; Jenkins, B; Thompson, C; Lam, W; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2013, FONTE: ADVANCES IN THERAPY, VOLUME: 30, NÚMERO: 9
5
TÃTULO: Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial Full Text
AUTORES: Cruz, F ; Herschorn, S; Aliotta, P; Brin, M; Thompson, C; Lam, W; Daniell, G; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2011, FONTE: EUROPEAN UROLOGY, VOLUME: 60, NÚMERO: 4
AUTORES: Cruz, F ; Herschorn, S; Aliotta, P; Brin, M; Thompson, C; Lam, W; Daniell, G; Heesakkers, J; Haag Molkenteller, C;
PUBLICAÇÃO: 2011, FONTE: EUROPEAN UROLOGY, VOLUME: 60, NÚMERO: 4
6
TÃTULO: EFFICACY AND SAFETY OF ONABOTULINUMTOXINA IN PATIENTS WITH URINARY INCONTINENCE DUE TO NEUROGENIC DETRUSOR OVERACTIVITY Full Text
AUTORES: Cruz, F ; Herschorn, S; Heesakkers, J; Aliotta, P; Thompson, C; Lam, W; Daniell, G; Haag Molkenteller, C;
PUBLICAÇÃO: 2011, FONTE: EUROPEAN UROLOGY SUPPLEMENTS, VOLUME: 10, NÚMERO: 2
AUTORES: Cruz, F ; Herschorn, S; Heesakkers, J; Aliotta, P; Thompson, C; Lam, W; Daniell, G; Haag Molkenteller, C;
PUBLICAÇÃO: 2011, FONTE: EUROPEAN UROLOGY SUPPLEMENTS, VOLUME: 10, NÚMERO: 2
INDEXADO EM: WOS
WOS